Long non-coding RNA expression profiles predict clinical phenotypes in glioma
- PMID: 22709987
- DOI: 10.1016/j.nbd.2012.06.004
Long non-coding RNA expression profiles predict clinical phenotypes in glioma
Abstract
Glioma is the commonest form of primary brain tumor in adults with varying malignancy grades and histological subtypes. Long non-coding RNAs (lncRNAs) are a novel class of non-protein-coding transcripts that have been shown to play important roles in cancer development. To discover novel tumor-related lncRNAs and determine their associations with glioma subtypes, we first applied a lncRNA classification pipeline to identify 1970 lncRNAs that were represented on Affymetrix HG-U133 Plus 2.0 array. We then analyzed the lncRNA expression patterns in a set of previously published glioma gene expression profiles of 268 clinical specimens, and identified sets of lncRNAs that were unique to different histological subtypes (astrocytic versus oligodendroglial tumors) and malignancy grades. These lncRNAs signatures were then subject to validation in another non-overlapping, independent data set that contained 157 glioma samples. This is the first reported study that correlates lncRNA expression profiles with malignancy grade and histological differentiation in human gliomas. Our findings indicate the potential roles of lncRNAs in the biogenesis, development and differentiation of gliomas, and provide an important platform for future studies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.Cancer Res. 2010 Dec 15;70(24):10060-70. doi: 10.1158/0008-5472.CAN-10-2465. Cancer Res. 2010. PMID: 21159630
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.Int J Oncol. 2012 Jun;40(6):2004-12. doi: 10.3892/ijo.2012.1413. Epub 2012 Mar 23. Int J Oncol. 2012. PMID: 22446686
-
Long non-coding RNAs in glioma: functional roles and clinical perspectives.Neurochem Int. 2014 Nov;77:78-85. doi: 10.1016/j.neuint.2014.05.008. Epub 2014 Jun 2. Neurochem Int. 2014. PMID: 24887176 Review.
-
Molecular pathways in the formation of gliomas.Glia. 1995 Nov;15(3):328-38. doi: 10.1002/glia.440150312. Glia. 1995. PMID: 8586467 Review.
Cited by
-
Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients.Front Genet. 2020 Jul 24;11:673. doi: 10.3389/fgene.2020.00673. eCollection 2020. Front Genet. 2020. PMID: 32849766 Free PMC article.
-
Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis.Int J Clin Exp Med. 2015 Apr 15;8(4):5033-43. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131076 Free PMC article.
-
Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.Onco Targets Ther. 2016 Jun 13;9:3501-9. doi: 10.2147/OTT.S96278. eCollection 2016. Onco Targets Ther. 2016. PMID: 27366087 Free PMC article.
-
Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway.Biosci Rep. 2020 Aug 28;40(8):BSR20201578. doi: 10.1042/BSR20201578. Biosci Rep. 2020. PMID: 32735016 Free PMC article.
-
Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma.Oncotarget. 2017 Jan 24;8(4):5789-5799. doi: 10.18632/oncotarget.11011. Oncotarget. 2017. PMID: 27494890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical